List of COVID-19 Resources for Journalists

inArticle, COVID-19
Jun 29, 2021

Below is a compilation of important resources regarding issues related to COVID-19.

1. Understanding Vaccine Landscape

2. Clinical Registry Trials & Ingredients

3. Vaccine Frequently Asked Questions (FAQs)

  • India FAQs, Ministry of Health & Family Welfare
  • Centers for Disease Control and Prevention (CDC), FAQs
  • ICMR FAQs in vernacular languages 
  • Sputnik FAQs, Apollo Hospitals
  • WHO FAQs, COVID-19 vaccines.    
  • Delta and Delta Plus Variants FAQs - Government of India
  • Guide to Parents: Kids and Delta variant, New York Times

4. Vaccine Procurement Data of Countries

  • Vaccine Procurement tracker, Duke University
  • Details of successive orders placed by the Government of India (GoI) for COVID-19 vaccines -  Affidavit of GoI in the Supreme Court on 26 June 2021.

5. Studies on Vaccine efficacy

  • Covaxin efficacy results, Bharat Biotech
  • Safety and Efficacy of the BNT162b2 mRNA Covid-19 Vaccine, The New England Journal of Medicine
  • Covishield efficacy study and study, The Lancet
  • Further evidence on vaccine studies: Safety and efficacy of Pfizer & AstraZeneca vaccines
  • Protective effect of COVID-19 vaccine among health care workers during the second wave of the pandemic in India
  • Efficacy of NVX-CoV2373 (Novavax) COVID-19 Vaccine against the B.1.351 Variant
  • Interim results of Phase 1–2a Trial of Ad26.COV2.S (Johnson & Johnson) COVID-19 Vaccine

6. Studies on Breakthrough cases

  • COVID-19 vaccine breakthrough case investigation and reporting, CDC
  • Breakthrough SARS-CoV-2 infections in an eastern state of India: A preliminary report
  • Tolerability and Immunogenicity after a late second dose or a third dose of ChAdOx1 nCoV-19 (AZD1222) - Lancet

7. Virus Variants Tracking

  • Tracking SARS-COV-2 variants, WHO
  • Coronavirus Variants and Mutations, The New York Times
  • Surveillance for SARS-CoV-2 Variants, CDC
  • SARS-CoV-2 Variant Classifications and Definitions, CDC
  • COVID-19 Variant Tracker, Axios Visuals
  • COVID-19 Variant Lineage, PANGO lineages
  • Genomic characterization and Epidemiology of an emerging SARS-CoV-2 variant in Delhi, India
  • Reduced sensitivity of infectious SARS-CoV-2 variant B.1.617.2 to monoclonal antibodies and sera from convalescent and vaccinated individuals
  • The Spike Proteins of SARS-CoV-2 B.1.617 and B.1.618 variants identified in India provide partial resistance to vaccine-elicited and therapeutic monoclonal antibodies. 

8. Studies on Virus Variants

9. Common Misinformation & Facts

Last updated on 3 July 2021

Previous Post

General vaccine trends in India -19

Recent Posts
© 2014-2022 Factly Media & Research | Except for videos, content on this site is licensed under a Creative Commons Attribution 4.0 International License.Creative Commons License